buyWeak
Anthony S Gibney bought $130k of CLSD
director at Clearside Biomedical, Inc.. 100,000 shares at an average of $1.30, traded Apr 17, 2024, filed Apr 19, 2024.
Conviction score
34Value
$130k
100,000 shares
Holdings after
100,000
change unknown
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- +11Trade size$130k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-24-011199, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 17, 2024 | POpen-market purchase Common Stock | +6,710 | $1.25 | $8,388 | 6,710 | Apr 19, 2024 |
| Apr 18, 2024 | POpen-market purchase Common Stock | +93,290 | $1.30 | $121k | 100,000 | Apr 19, 2024 |
Related signals
Other insiders at Clearside Biomedical, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 18Weak | CLSDbuy Clearside Biomedical, Inc. | Clay Thorp director | $14k 15,000 shares | +9% | |
| 31Weak | CLSDbuy Clearside Biomedical, Inc. | Ngai Hang Victor Chong Chief Medical Officer | $37k 36,500 shares | +57% | |
| 25Weak | CLSDbuy Clearside Biomedical, Inc. | Ngai Hang Victor Chong Chief Medical Officer | $25k 23,500 shares | +59% | |
| 25Weak | CLSDbuy Clearside Biomedical, Inc. | Benjamin R Yerxa director | $10k 7,813 shares | +77% | |
| 30Weak | CLSDbuy Clearside Biomedical, Inc. | Ngai Hang Victor Chong CHIEF MEDICAL OFFICER | $48k 30,000 shares | - | |
| 24Weak | CLSDbuy Clearside Biomedical, Inc. | Bradford T Whitmore owner | $600k 444,444 shares | +11% | |
| 30Weak | Clearside Biomedical, Inc. | Charles A. Deignan Chief Financial Officer | $17k 12,900 shares | -3% | |
| 33Weak | Clearside Biomedical, Inc. | George M Lasezkay CEO | $23k 18,000 shares | -4% | |
| 12Weak | CLSDbuy Clearside Biomedical, Inc. | Bradford T Whitmore owner | $100k 135,778 shares | +3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.